| Overview |
| bsm-62800r-pe-100ul |
| p45 NF-E2 Recombinant Monoclonal Antibody, PE Conjugated |
| WB, IF(ICC) |
| Human |
| Specifications |
| PE |
| Rabbit |
| KLH conjugated synthetic peptide derived from human NFE2 |
| Monoclonal |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 4778 |
| Q16621 |
| Nucleus |
| nfe2 ; Nuclear factor; p45 NFE2. |
| Component of the NF-E2 complex essential for regulating erythroid and megakaryocytic maturation and differentiation. Binds to the hypersensitive site 2 (HS2) of the beta-globin control region (LCR). This subunit (NFE2) recognizes the TCAT/C sequence of the AP-1-like core palindrome present in a number of erythroid and megakaryocytic gene promoters. Requires MAFK or other small MAF proteins for binding to the NF-E2 motif. May play a role in all aspects of hemoglobin production from globin and heme synthesis to procurement of iron. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(ICC) |
1:50-200 |
Powered by Bioz